540 related articles for article (PubMed ID: 25842185)
1. Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases.
Tran TH; Mattheolabakis G; Aldawsari H; Amiji M
Clin Immunol; 2015 Sep; 160(1):46-58. PubMed ID: 25842185
[TBL] [Abstract][Full Text] [Related]
2. Designer exosomes as next-generation cancer immunotherapy.
Bell BM; Kirk ID; Hiltbrunner S; Gabrielsson S; Bultema JJ
Nanomedicine; 2016 Jan; 12(1):163-9. PubMed ID: 26500074
[TBL] [Abstract][Full Text] [Related]
3. [Exosomes and anti-tumour immunotherapy].
Chaput N; Andre F; Schartz NE; Flament C; Angevin E; Escudier B; Zitvogel L
Bull Cancer; 2003; 90(8-9):695-8. PubMed ID: 14609758
[TBL] [Abstract][Full Text] [Related]
4. Exosome-based immunotherapy.
Chaput N; Taïeb J; Schartz NE; André F; Angevin E; Zitvogel L
Cancer Immunol Immunother; 2004 Mar; 53(3):234-9. PubMed ID: 14727085
[TBL] [Abstract][Full Text] [Related]
5. [Exosome: Trojan horse in immunotherapy].
Mou DL; Jia ZS; Bai XF
Sheng Li Ke Xue Jin Zhan; 2005 Apr; 36(2):113-8. PubMed ID: 16222969
[TBL] [Abstract][Full Text] [Related]
6. REMEDIAL APPLICATIONS OF EXOSOMES IN CANCER, INFECTIONS AND DIABETES.
Wang Q; Ding X; Zhen F; Ma J; Meng F
Acta Pol Pharm; 2017 Mar; 74(2):313-320. PubMed ID: 29624236
[TBL] [Abstract][Full Text] [Related]
7. Exosomes as drug carriers for clinical application.
Di C; Zhang Q; Wang Y; Wang F; Chen Y; Gan L; Zhou R; Sun C; Li H; Zhang X; Yang H; Zhang H
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S564-S570. PubMed ID: 30431368
[TBL] [Abstract][Full Text] [Related]
8. Harnessing the exosome-induced immune response for cancer immunotherapy.
Gehrmann U; Näslund TI; Hiltbrunner S; Larssen P; Gabrielsson S
Semin Cancer Biol; 2014 Oct; 28():58-67. PubMed ID: 24859748
[TBL] [Abstract][Full Text] [Related]
9. [The Functional Role of Exosomes in Cancer Biology and Their Potential as Biomarkers and Therapeutic Targets of Cancer].
Naito Y; Yoshioka Y; Ochiya T
Gan To Kagaku Ryoho; 2015 Jun; 42(6):647-55. PubMed ID: 26199235
[TBL] [Abstract][Full Text] [Related]
10. Cancer immunotherapy using dendritic cell-derived exosomes.
Amigorena S
Medicina (B Aires); 2000; 60 Suppl 2():51-4. PubMed ID: 11188932
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell-derived exosomes as immunotherapies in the fight against cancer.
Pitt JM; Charrier M; Viaud S; André F; Besse B; Chaput N; Zitvogel L
J Immunol; 2014 Aug; 193(3):1006-11. PubMed ID: 25049431
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
Johnsen KB; Gudbergsson JM; Skov MN; Pilgaard L; Moos T; Duroux M
Biochim Biophys Acta; 2014 Aug; 1846(1):75-87. PubMed ID: 24747178
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-based autoimmune disease therapy.
Serra P; Santamaria P
Clin Immunol; 2015 Sep; 160(1):3-13. PubMed ID: 25704658
[TBL] [Abstract][Full Text] [Related]
14. Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy.
Nam GH; Choi Y; Kim GB; Kim S; Kim SA; Kim IS
Adv Mater; 2020 Dec; 32(51):e2002440. PubMed ID: 33015883
[TBL] [Abstract][Full Text] [Related]
15. From the antigen-presenting cell to the antigen-presenting vesicle: the exosomes.
Schartz NE; Chaput N; André F; Zitvogel L
Curr Opin Mol Ther; 2002 Aug; 4(4):372-81. PubMed ID: 12222875
[TBL] [Abstract][Full Text] [Related]
16. Potential therapeutic applications of exosomes in different autoimmune diseases.
Xu H; Jia S; Xu H
Clin Immunol; 2019 Aug; 205():116-124. PubMed ID: 31228581
[TBL] [Abstract][Full Text] [Related]
17. How can nanotechnology help membrane vesicle-based cancer immunotherapy development?
Tian X; Zhu M; Nie G
Hum Vaccin Immunother; 2013 Jan; 9(1):222-5. PubMed ID: 23108359
[TBL] [Abstract][Full Text] [Related]
18. Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer.
Srivastava A; Babu A; Filant J; Moxley KM; Ruskin R; Dhanasekaran D; Sood AK; McMeekin S; Ramesh R
J Biomed Nanotechnol; 2016 Jun; 12(6):1159-73. PubMed ID: 27319211
[TBL] [Abstract][Full Text] [Related]
19. Stem cell-derived exosomes: roles in stromal remodeling, tumor progression, and cancer immunotherapy.
Fatima F; Nawaz M
Chin J Cancer; 2015 Sep; 34(12):541-53. PubMed ID: 26369565
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-induced exosomes target antigen-presenting cells to initiate Th1-type immune activation.
Zhu M; Tian X; Song X; Li Y; Tian Y; Zhao Y; Nie G
Small; 2012 Sep; 8(18):2841-8. PubMed ID: 22674628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
